1,3-ditolylguanidine has been researched along with ascorbic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Calabretti, A; Collina, S; Fortuna, S; Mamolo, MG; Menegazzi, R; Romano, M; Schepmann, D; Wünsch, B; Zampieri, D; Zanon, D | 1 |
| Calabretti, A; Fortuna, S; Mamolo, MG; Menegazzi, R; Romano, M; Schepmann, D; Wünsch, B; Zampieri, D | 1 |
2 other study(ies) available for 1,3-ditolylguanidine and ascorbic acid
| Article | Year |
|---|---|
Discovery of new potent dual sigma receptor/GluN2b ligands with antioxidant property as neuroprotective agents.
Topics: Antioxidants; Benzothiazoles; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Discovery; Humans; Hydrogen Peroxide; Ligands; Models, Molecular; Molecular Structure; Neuroprotective Agents; Oxadiazoles; Oxidative Stress; Quinolones; Receptors, N-Methyl-D-Aspartate; Receptors, sigma; Structure-Activity Relationship; Sulfonic Acids | 2019 |
Synthesis, Cytotoxicity Evaluation, and Computational Insights of Novel 1,4-Diazepane-Based Sigma Ligands.
Topics: | 2020 |